|
Positive studies | Negative studies |
Study | No. of participants | Drug | Comments | Study | No. of participants | Drug | Comments |
|
Antidepressants as monotherapy | | | | | | |
Amsterdam and Shults 2005 [13] | 34 (, ) | Fluoxetine, olanzapine/fluoxetine combination | No placebo control | McElroy et al. 2010 (EMBOLDEN II) [14] | 740 (, ) | Paroxetine | |
Parker et al. 2006 [16] | 10 BPII | Escitalopram | Small sample size | | | | |
Agosti and Stewart 2007 [21] | 70 BP II | Imipramine, phenelzine | No significance demonstrated | | | | |
Amsterdam and Shults 2008 [17] | 83 BPII | Venlafaxine | No placebo control | | | | |
Amsterdam and Shults 2010 [15] | 148 BPII | Fluoxetine | No placebo control | | | | |
|
Antidepressants with mood stabilizers | | | | | | |
Schaffer et al. 2006 [27] | 20 | Citalopram | Small sample size, no placebo control | Sachs et al. 2007 [29] | 366 (, ) | Paroxetine, bupropion | |
Fonseca et al. 2006 [28] | 20 | Escitalopram | Small sample size, no placebo control | Sidor et al. 2011 [32] | 1,034 (Meta- Analysis) | Fluoxetine, paroxetine, bupropion, imipramine | |
Tamayo et al. 2009 [46] | 114 | Olanzapine/fluoxetine combination | Conducted by Lilly Research Laboratories | | | | |
Pilhatsch et al. 2010 [41] | 40 | Paroxetine, amitriptyline | No placebo control | | | | |
Perlis et al. 2010 [45] | 410 | Olanzapine/fluoxetine combination | Conducted by Lilly Research Laboratories | | | | |
|